References
- ALVI NG, C. R., KOULCHIN, V., GLENN, G. M., and RAO, M., 1995, Liposomes as carriers of peptide antigens: induction of antibodies and cytotoxic T lymphocytes to conjugated and unconjugated peptides. Immunological Reviews, 145, 5–31.
- AUDER, C., RAMIREZ, J., SOLER, E., and CARREIRA, J., 1991, Liposomes as carriers for allergy immunotherapy. Clinical and Experimental Allergy, 21, 139–144.
- BEI, R., GUPTILL, V., MASUELLI, L., KASHMIRI, S. V., MURARO, R., FRATI, L., SCHLOM, J., and KANTOR, J., 1998, The use of a cationic liposome formulation (DOTAP) mixed with a recombinant tumor-associated antigen to induce immune responses and protective immunity in mice. Journal of Immunotherapy, 21, 159–169.
- COUVREUR, P., FATTAL, E., and ANDREMONT, A., 1991, Liposomes and nanoparticles in the treatment of intracellular bacterial infections. Pharmaceutical Research, 8, 1079–1086.
- FATUNMBI 0. 0., NEWMAN, J. A., S IVANANDAN, V., and HALVORSON, D. A., 1992, Enhancement of antibody response of turkeys to trivalent avian influenza vaccine by positively charged liposomal avridine adjuvant. Vaccine, 10, 623–626.
- FRIEDE, M., MULLER, S., BRI AND, J. P., UAN REGENMORTEL, M. H., and SCHUBER, F., 1993, Induction of immune response against a short synthetic peptide antigen coupled to small neutral liposomes containing monophosphoryl lipid A. Molecular Immunology, 30, 539–547.
- GLucK, R., 1995, Liposomal presentation of antigens for human vaccines. Pharmaceutical Biotechnology, 6, 325–345.
- GREGORIADIS, G., 1994, The immunological adjuvant and vaccine carrier properties of liposomes. Journal of Drug Targeting, 2, 351–356.
- GUM-A, P. K., and HUNG, C. T., 1989, Quantitative evaluation of targeted drug delivery systems. International Journal of Pharmaceutics, 56, 217–226.
- KIM, C.-K., and HWANG, S. J., 1993, Pharmacokinetics and organ distribution of 3H-methotrexate and 3H-methotrexate-human serum albumin conjugates in mice. Drug Development and Industrial Pharmacy, 19, 961–970.
- KIM, C.-K., and JEONG, E. J., 1995, Development of dried liposomes as effective immuno-adjuvant for hepatitis B surface antigen. International Journal of Pharmaceutics, 115, 193–199.
- KIM, C.K., and JEONG, E. J., 1997, Enhanced lymph node delivery and immunogenicity of hepatitis B surface antigen incorporated in galactosylated liposomes. International Journal of Pharmaceutics, 147, 143–151.
- LAMBROS, M. P., SCHAFER, F., BLACKSTOCK, R., and MURPHY, J. W., 1998, Liposomes, a potential immunoadjuvant and carrier for a cryptococcal vaccine. Journal of Pharmaceutical Sciences, 87, 1144–1148.
- LATIF, N., and BACHHAWAT, B. K., 1984, The effect of surface charges of liposomes in immunopotentiation. Bioscience Reports, 4, 99–107.
- MANESIS, E. K., CAMERON, C. H., and GREGORIADIS, G., 1979, Hepatitis B surface antigen-containing liposomes enhance humoral and cell-mediated immunity to the antigen. Biochemical Society Transactions, 7, 678–690.
- NAKANISHI, T., KUNISAWA, J., HAYASHI, A., TSUTSUMI, Y., KUBO, K., NAKAGAWA, S., FUJIWARA, H., HAMAOKA, T., and MAYUMI, T., 1997, Positively charged liposome functions as an efficient immunoadjuvant in inducing immune responses to soluble proteins. Biochemical and Biophysical Research Communications, 240, 793–797.
- NEW, R. R. C., 1990, Preparation of liposomes. Liposomes; A practical Approach (New York: IRL Press), pp. 33–104.
- PHILLIPS, N. C., GAGNE, L., IVANOFF, N., and RIVEAU, G., 1996, Influence of phospholipid composition on antibody responses to liposome encapsulated protein and peptide antigens. Vaccine, 14, 898–904.
- PoL, S., 1995, Immunotherapy of chronic hepatitis B by anti HBV vaccine. Biomedical Pharmacotherapy, 49, 105–109.
- STEWART, J. C. M., 1980, Colorimetric determination of phospholipids with ammonium ferrocyanate. Analytical Biochemistry, 104, 10–14.